Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Endeavor Drug-Eluting Stent Is First to Receive CE Mark for Treating Acute Coronary Syndrome
Medtronic, 05/20/09

Medtronic, Inc., today announced that its Endeavor drug-eluting stent is the first and only coronary stent to have received CE Mark approval for treating patients with acute coronary syndrome, which includes unstable angina and acute myocardial infarction, commonly known as heart attack.

Today in Drug/Product Approvals...keeping you current

Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

 See all of Drug/Product Approvals

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address